Position in MNKD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,042,314
+$775,676 QoQ
Shares Held
244,675
+124.8% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $452,608,635 across 219 Biotechnology names. MNKD ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in MNKD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,042,314 | 244,675 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $266,638 | 108,832 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $973,862 | 171,757 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $964,113 | 179,537 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $431,763 | 115,445 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $573,585 | 114,033 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $767,458 | 119,356 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $744,849 | 118,418 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $693,095 | 132,777 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $421,824 | 93,118 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $345,989 | 95,052 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $392,077 | 94,934 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $446,592 | 109,728 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $446,900 | 109,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $529,266 | 100,430 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $338,874 | 109,668 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $398,891 | 104,696 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $451,134 | 122,591 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $543,492 | 124,369 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $521,230 | 119,823 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $650,310 | 119,323 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $471,830 | 120,365 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $530,497 | 169,488 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $319,440 | 169,915 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $296,301 | 169,315 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $174,909 | 169,815 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||